source
- BioNTech appoints Guido Oelkers as new CEO, succeeding cofounder Ugur SahinBioNTech announced that Guido Oelkers will become its chief executive officer, taking over from cofounder Ugur Sahin. Oelkers comes from Swedish biopharma Sobi, where he led the company, and bring…
- In-patient cardiac pre-hab program launched to keep heart-transplant candidates fit while awaiting surgeryPatients waiting in the hospital for a heart transplant often lose strength and can become ineligible for the procedure as their fitness declines. To address this, Dr. Radha Gopalan at Banner‑Univ…